SpringerLink
Log in

Perioperative risk stratification scores in infective endocarditis and its usefulness

  • Review Article
  • Published:
Indian Journal of Thoracic and Cardiovascular Surgery Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Infective endocarditis continues to represent a serious disease worldwide with high morbidity and mortality rates despite advances in diagnosis and treatment. Risk assessment plays a pivotal role in determining the appropriate course of treatment for patients diagnosed with infective endocarditis. In this context, specific endocarditis risk scores have been developed trying to help in the risk assessment process. During the last 15 years, 19 specific endocarditis scores have been published. These newly created scores are very heterogenous in their characteristics, factors included, and validation strategies. The purpose of this review is to analyze the published specific infective endocarditis risk scores and discuss their advantages, limitations, and usefulness.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Yang X, Chen H, Zhang D, Shen L, An G, Zhao S. Global magnitude and temporal trend of infective endocarditis, 1990–2019: results from the Global Burden of Disease Study. Eur J Prev Cardiol. 2022;29:1277–86.

    Article  PubMed  Google Scholar 

  2. Ambrosioni J, Hernández-Meneses M, Durante-Mangoni E, Tattevin P, Olaison L, Freiberger T, et al. Epidemiological changes and improvement in outcomes of infective endocarditis in Europe in the twenty-first century: an international collaboration on endocarditis (ICE) prospective cohort study (2000–2012). Infect Dis Ther. 2023;12:1083–101.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Benito N, Miró JM, de Lazzari E, Cabell CH, del Río A, Altclas J, et al. Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. Ann Intern Med. 2009;150:586–94.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36:3075–128.

    Article  PubMed  Google Scholar 

  5. Sy RW, Kritharides L. Health care exposure and age in infective endocarditis: results of a contemporary population-based profile of 1536 patients in Australia. Eur Heart J. 2010;31:1890–7.

    Article  PubMed  Google Scholar 

  6. Thornhill MH, Dayer MJ, Nicholl J, Prendergast BD, Lockhart PB, Baddour LM. An alarming rise in incidence of infective endocarditis in England since 2009: why? Lancet Lond Engl. 2020;395:1325–7.

    Article  Google Scholar 

  7. Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG, Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009;169:463–73.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Delgado V, Ajmone Marsan N, de Waha S, Bonaros N, Brida M, Burri H, et al. 2023 ESC guidelines for the management of endocarditis. Eur Heart J. 2023;44:3948–4042. https://doi.org/10.1093/eurheartj/ehad193. Erratum in: Eur Heart J. 2023 Sep 20;

    Article  PubMed  Google Scholar 

  9. Habib G, Erba PA, Iung B, Donal E, Cosyns B, Laroche C, et al. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J. 2019;40:3222–32.

    Article  PubMed  Google Scholar 

  10. Pazdernik M, Iung B, Mutlu B, Alla F, Riezebos R, Kong W, et al. Surgery and outcome of infective endocarditis in octogenarians: prospective data from the ESC EORP EURO-ENDO registry. Infection. 2022;50:1191–202.

    Article  PubMed  Google Scholar 

  11. Ambrosioni J, Hernandez-Meneses M, Téllez A, Pericàs J, Falces C, Tolosana JM, et al. The changing epidemiology of infective endocarditis in the twenty-first century. Curr Infect Dis Rep. 2017;19:21.

    Article  CAS  PubMed  Google Scholar 

  12. Prendergast BD, Tornos P. Surgery for infective endocarditis: who and when? Circulation. 2010;121:1141–52.

    Article  PubMed  Google Scholar 

  13. Pettersson GB, Hussain ST. Current AATS guidelines on surgical treatment of infective endocarditis. Ann Cardiothorac Surg. 2019;8:630–44.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Shahian DM, Jacobs JP, Badhwar V, Kurlansky PA, Furnary AP, Cleveland JC, et al. The society of thoracic surgeons 2018 adult cardiac surgery risk models: part 1—background, design considerations, and model development. Ann Thorac Surg. 2018;105:1411–8.

    Article  PubMed  Google Scholar 

  15. O’Brien SM, Feng L, He X, **an Y, Jacobs JP, Badhwar V, et al. The society of thoracic surgeons 2018 adult cardiac surgery risk models: part 2—statistical methods and results. Ann Thorac Surg. 2018;105:1419–28.

    Article  PubMed  Google Scholar 

  16. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg. 1999;16:9–13.

    Article  CAS  Google Scholar 

  17. Nashef SA, Roques F, Sharples LD, Nilsson J, Smith C, Goldstone AR, Lockowandt U. EuroSCORE II. Eur J Cardiothorac Surg. 2012;41:734–44.

    Article  PubMed  Google Scholar 

  18. Rasmussen RV, Bruun LE, Lund J, Larsen CT, Hassager C, Bruun NE. The impact of cardiac surgery in native valve infective endocarditis: can euroSCORE guide patient selection? Int J Cardiol. 2011;149:304–9.

    Article  PubMed  Google Scholar 

  19. Lalani T, Cabell CH, Benjamin DK, Lasca O, Naber C, Fowler VG, et al. Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for treatment-selection bias. Circulation. 2010;121:1005–13.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Martínez-Sellés M, Muñoz P, Arnáiz A, Moreno M, Gálvez J, Rodríguez-Roda J, et al. Valve surgery in active infective endocarditis: a simple score to predict in-hospital prognosis. Int J Cardiol. 2014;175:133–7.

    Article  PubMed  Google Scholar 

  21. Chu VH, Park LP, Athan E, Delahaye F, Freiberger T, Lamas C, et al. Association between surgical indications, operative risk, and clinical outcome in infective endocarditis: a prospective study from the international collaboration on endocarditis. Circulation. 2015;131:131–40.

    Article  PubMed  Google Scholar 

  22. Varela Barca L, López-Menéndez J, Redondo Palacios A, Rodríguez-Roda J. External validation of the new predictive model for early mortality after surgical treatment of infective endocarditis: analysis of the reliability of EndoSCORE. Int J Cardiol. 2018;268:99.

    Article  PubMed  Google Scholar 

  23. Wang T, Pemberton J. Performance of Endocarditis-Specific Risk Scores in Surgery for Infective Endocarditis. Thorac Cardiovasc Surg. 2018;66:333–5.

    Article  CAS  PubMed  Google Scholar 

  24. Rizzo V, Salmasi MY, Sabetai M, Primus C, Sandoe J, Lewis M, et al. Infective endocarditis: do we have an effective risk score model? A systematic review. Front Cardiovasc Med. 2023;10:1093363.

    Article  PubMed  Google Scholar 

  25. Fernández-Cisneros A, Hernández-Meneses M, Llopis J, Sandoval E, Pereda D, Alcocer J, et al. Risk scores’ performance and their impact on operative decision-making in left-sided endocarditis: a cohort study. Eur J Clin Microbiol Infect Dis. 2023;42:33–42.

    Article  PubMed  Google Scholar 

  26. Varela Barca L, Navas Elorza E, Fernández-Hidalgo N, Moya Mur JL, Muriel García A, Fernández-Felix BM, et al. Prognostic factors of mortality after surgery in infective endocarditis: systematic review and meta-analysis. Infection. 2019;47:879–95.

    Article  CAS  PubMed  Google Scholar 

  27. Costa MACD, Wollmann DR Jr, Campos ACL, Cunha CLPD, Carvalho RGD, Andrade DFD, et al. Índice de risco de mortalidade por endocardite infecciosa: um modelo logístico multivariado. Rev Bras Cir Cardiovasc. 2007;22.

  28. Gaca JG, Sheng S, Daneshmand MA, O’Brien S, Rankin JS, Brennan JM, et al. Outcomes for endocarditis surgery in North America: a simplified risk scoring system. J Thorac Cardiovasc Surg. 2011;141:98–106.e1-2.

    Article  PubMed  Google Scholar 

  29. López J, Fernández-Hidalgo N, Revilla A, Vilacosta I, Tornos P, Almirante B, et al. Internal and external validation of a model to predict adverse outcomes in patients with left-sided infective endocarditis. Heart Br Card Soc. 2011;97:1138–42.

    Article  Google Scholar 

  30. De Feo M, Cotrufo M, Carozza A, De Santo LS, Amendolara F, Giordano S, et al. The need for a specific risk prediction system in native valve infective endocarditis surgery. Sci World J. 2012;2012:1–8.

    Article  Google Scholar 

  31. Bjurman C, Snygg-Martin U, Olaison L, Fu MLX, Hammarsten O. Cystatin C in a composite risk score for mortality in patients with infective endocarditis: a cohort study. BMJ Open. 2012;2:e000856.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Grubb A, Björk J, Nyman U, Pollak J, Bengzon J, Östner G, et al. Cystatin C, a marker for successful aging and glomerular filtration rate, is not influenced by inflammation. Scand J Clin Lab Invest. 2011;71:145–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Chee QZ, Tan YQB, Ngiam JN, Win MTM, Shen X, Choo JNJ, et al. The SHARPEN clinical risk score predicts mortality in patients with infective endocarditis: an 11-year study. Int J Cardiol. 2015;191:273–6.

    Article  PubMed  Google Scholar 

  34. Alves SG, Pivatto Júnior F, Filippini FB, Dannenhauer GP, Miglioranza MH. SHARPEN score accurately predicts in-hospital mortality in infective endocarditis. Eur J Intern Med. 2021;92:124–7.

    Article  PubMed  Google Scholar 

  35. Park LP, Chu VH, Peterson G, Skoutelis A, Lejko-Zupa T, Bouza E, et al. Validated risk score for predicting 6-month mortality in infective endocarditis. J Am Heart Assoc. 2016;5:e003016.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Di Mauro M, Dato GMA, Barili F, Gelsomino S, Santè P, Corte AD, et al. A predictive model for early mortality after surgical treatment of heart valve or prosthesis infective endocarditis. The EndoSCORE. Int J Cardiol. 2017;241:97–102.

    Article  PubMed  Google Scholar 

  37. Gatti G, Perrotti A, Obadia J, Duval X, Iung B, Alla F, et al. Simple scoring system to predict in-hospital mortality after surgery for infective endocarditis. J Am Heart Assoc. 2017;6:e004806.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Olmos C, Vilacosta I, Habib G, Maroto L, Fernández C, López J, et al. Risk score for cardiac surgery in active left-sided infective endocarditis. Heart. 2017;103:1435–42.

    Article  PubMed  Google Scholar 

  39. Gelsomino S, Maessen JG, van der Veen F, Livi U, Renzulli A, Lucà F, et al. Emergency surgery for native mitral valve endocarditis: the impact of septic and cardiogenic shock. Ann Thorac Surg. 2012;93:1469–76.

    Article  PubMed  Google Scholar 

  40. Varela Barca L, López-Menéndez J, Miguelena Hycka J, Redondo Palacios A, Fajardo Rodríguez ER, Martín García M, et al. Valor pronóstico de la trombocitopenia preoperatoria en la cirugía de la endocarditis infecciosa: experiencia de un centro. Cir Cardiovasc. 2018;25:268–73.

    Google Scholar 

  41. Gatti G, Benussi B, Gripshi F, Della Mattia A, Proclemer A, Cannatà A, et al. A risk factor analysis for in-hospital mortality after surgery for infective endocarditis and a proposal of a new predictive scoring system. Infection. 2017;45:413–23.

    Article  PubMed  Google Scholar 

  42. Fernández-Hidalgo N, Ferreria-González I, Marsal JR, Ribera A, Aznar ML, de Alarcón A, et al. A pragmatic approach for mortality prediction after surgery in infective endocarditis: optimizing and refining EuroSCORE. Clin Microbiol Infect. 2018;24:1102.e7–1102.e15.

    Article  PubMed  Google Scholar 

  43. Cheng HP, Biao WX, Ni LS, Lan CX, Hui KZ, Qing YD, et al. Risk prediction in infective endocarditis by modified MELD-XI score. Eur J Clin Microbiol Infect Dis. 2018;37:1243–50.

    Article  Google Scholar 

  44. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatol Baltim Md. 2001;33:464–70.

    Article  CAS  Google Scholar 

  45. Inohara T, Kohsaka S, Shiraishi Y, Goda A, Sawano M, Yagawa M, et al. Prognostic impact of renal and hepatic dysfunction based on the MELD-XI score in patients with acute heart failure. Int J Cardiol. 2014;176:571–3.

    Article  PubMed  Google Scholar 

  46. Kim MS, Kato TS, Farr M, Wu C, Givens RC, Collado E, et al. Hepatic dysfunction in ambulatory patients with heart failure: application of the MELD scoring system for outcome prediction. J Am Coll Cardiol. 2013;61:2253–61.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Wei XB, Su ZD, Liu YH, Wang Y, Huang JL, Yu DQ, et al. Age, creatinine and ejection fraction (ACEF) score: a simple risk-stratified method for infective endocarditis. QJM Mon J Assoc Physicians. 2019;112:900–6.

    Article  Google Scholar 

  48. Ranucci M, Castelvecchio S, Menicanti L, Frigiola A, Pelissero G. Risk of assessing mortality risk in elective cardiac operations: age, creatinine, ejection fraction, and the law of parsimony. Circulation. 2009;119:3053–61.

    Article  PubMed  Google Scholar 

  49. Varela Barca L, Fernández-Felix BM, Navas Elorza E, Mestres CA, Muñoz P, Cuerpo-Caballero G, et al. Prognostic assessment of valvular surgery in active infective endocarditis: multicentric nationwide validation of a new score developed from a meta-analysis. Eur J Cardiothorac Surg. 2020;57:724–31.

    Article  PubMed  Google Scholar 

  50. García-Granja PE, López J, Vilacosta I, Sarriá C, Domínguez F, Ladrón R, et al. Predictive model of in-hospital mortality in left-sided infective endocarditis. Rev Esp Cardiol Engl Ed. 2020;73:902–9.

    Article  PubMed  Google Scholar 

  51. Garcia Granja PE, Lopez J, Vilacosta I, Saéz C, Cabezón G, Olmos C, et al. Prognostic impact of cardiac surgery in left-sided infective endocarditis according to risk profile. Heart. 2021;107:1987–94.

    Article  PubMed  Google Scholar 

  52. Fernandez-Felix BM, Barca LV, Garcia-Esquinas E, Correa-Pérez A, Fernández-Hidalgo N, Muriel A, et al. Prognostic models for mortality after cardiac surgery in patients with infective endocarditis: a systematic review and aggregation of prediction models. Clin Microbiol Infect. 2021;27:1422–30.

    Article  PubMed  Google Scholar 

  53. Luo L, Huang S, Liu C, Liu Q, Dong S, Yue Y, et al. Machine learning–based risk model for predicting early mortality after surgery for infective endocarditis. J Am Heart Assoc. 2022;11:e025433.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Kumar A, Anstey C, Tesar P, Shekar K. Risk factors for mortality in patients undergoing cardiothoracic surgery for infective endocarditis. Ann Thorac Surg. 2019;108:1101–6.

    Article  PubMed  Google Scholar 

  55. Jakuska P, Ereminiene E, Muliuolyte E, Kosys V, Pavlavičius L, Zukovas G, et al. Predictors of early mortality after surgical treatment of infective endocarditis: a single-center experience. Perfusion. 2020;35:290–6.

    Article  PubMed  Google Scholar 

  56. Ramspek CL, Jager KJ, Dekker FW, Zoccali C, van Diepen M. External validation of prognostic models: what, why, how, when and where? Clin Kidney J. 2021;14:49–58.

    Article  PubMed  Google Scholar 

  57. Altman DG, Vergouwe Y, Royston P, Moons KGM. Prognosis and prognostic research: validating a prognostic model. BMJ. 2009;338:b605.

    Article  PubMed  Google Scholar 

  58. Gatti G, Sponga S, Peghin M, Givone F, Ferrara V, Benussi B, et al. Risk scores and surgery for infective endocarditis: in search of a good predictive score. Scand Cardiovasc J. 2019;53:117–24.

    Article  PubMed  Google Scholar 

  59. Urso S, Tena MÁ, Horcajada I, Paredes F, González-Barbeito M, Portela F. Prediction of surgical risk in patients with endocarditis: Comparison of logistic EuroSCORE, EuroSCORE II and APORTEI score. Enfermedades Infecc Microbiol Clínica. 2021;39:244–7.

    Article  Google Scholar 

  60. Varela L, López-Menéndez J, Redondo A, Fajardo ER, Miguelena J, Centella T, et al. Mortality risk prediction in infective endocarditis surgery: reliability analysis of specific scores†. Eur J Cardiothorac Surg. 2018;53:1049–54.

    Article  PubMed  Google Scholar 

  61. Varela L, Vidal L, Fernández-Felix BM, Ventosa G, Navas E, Hidalgo I, et al. Estimación de la mortalidad quirúrgica de la endocarditis infecciosa: comparación de las diferentes escalas específicas de cálculo de riesgo. Cir Cardiovasc. 2020;27:93–9.

    Google Scholar 

  62. Wang TKM, Wang MTM, Pemberton J. Risk scores and surgery for infective endocarditis: A meta-analysis. Int J Cardiol. 2016;222:1001–2.

    Article  PubMed  Google Scholar 

  63. Moons KGM, Wolff RF, Riley RD, Whiting PF, Westwood M, Collins GS, et al. PROBAST: a tool to assess risk of bias and applicability of prediction model studies: explanation and elaboration. Ann Intern Med. 2019;170:W1–33.

    Article  PubMed  Google Scholar 

  64. Iung B, Doco-Lecompte T, Chocron S, Strady C, Delahaye F, Le Moing V, et al. Cardiac surgery during the acute phase of infective endocarditis: discrepancies between European Society of Cardiology guidelines and practices. Eur Heart J. 2016;37:840–8.

    Article  PubMed  Google Scholar 

  65. Gatti G, Chocron S, Obadia JF, Duval X, Iung B, Alla F, et al. Using surgical risk scores in nonsurgically treated infective endocarditis patients. Hellenic J Cardiol. 2020;61:246–52.

    Article  PubMed  Google Scholar 

  66. Varela Barca L, López-Menéndez J, Navas Elorza E, Moya Mur JL, Centella Hernéndez T, Redondo Palacios A, et al. Long-term prognosis after surgery for infective endocarditis: distinction between predictors of early and late survival. Enfermedades Infecc Microbiol Clínica. 2019;37:435–40.

    Article  Google Scholar 

  67. Ramos-Martínez A, Calderón-Parra J, Miró JM, Muñoz P, Rodríguez-Abella H, Valerio M, et al. Effect of the type of surgical indication on mortality in patients with infective endocarditis who are rejected for surgical intervention. Int J Cardiol. 2019;282:24–30.

    Article  PubMed  Google Scholar 

Download references

Funding

Nil.

Author information

Authors and Affiliations

  1. Cardiac Surgery Department, La Princesa University Hospital, Madrid, Spain

    Laura Varela-Barca

  2. Cardiac Surgery Department, Ramón y Cajal University Hospital, Madrid, Spain

    Jose López-Menéndez

Authors
  1. Laura Varela-Barca
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jose López-Menéndez
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contribute in the review development, editing, and correction.

Corresponding author

Correspondence to Laura Varela-Barca.

Ethics declarations

Conflict of interest

None declared.

Ethics approval

Not applicable.

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Data availability

The articles reviewed are mentioned as references.

Code availability

Not applicable.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Table S1

Score calculation of the infective endocarditis scores and the mortality rate prediction. (DOCX 1327 kb)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Varela-Barca, L., López-Menéndez, J. Perioperative risk stratification scores in infective endocarditis and its usefulness. Indian J Thorac Cardiovasc Surg 40 (Suppl 1), 47–60 (2024). https://doi.org/10.1007/s12055-023-01644-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12055-023-01644-y

Keywords

Search

Navigation